You are here

Sanofi

Sanofi drug Dupixent wins U.S. FDA approval to treat asthma

Sanofi drug Dupixent wins U.S. FDA approval to treat asthma

Yahoo/Reuters

Flag link:

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Biopharma Dive

Flag link:

Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs

Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs

BioSpace

Flag link:

Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII

Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII

Endpoints

Flag link:

Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS field?

Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS field?

Fierce Pharma

multiple sclerosis

Flag link:

Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery

Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery

BioSpace

drug development

Flag link:

Vaxart Stock Soars on Oral Flu Vaccine Results

Vaxart Stock Soars on Oral Flu Vaccine Results

CP Wire

Flag link:

Vaxart Stock Soars on Oral Flu Vaccine Results

Flag link:

Recipharm acquires Sanofi inhalation contract manufacturing business

Recipharm acquires Sanofi inhalation contract manufacturing business

Pharmaceutical Business Review

drug manufacturing

contract drug manufacturing

inhalation drugs

Flag link:

Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug

Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug

Bloomberg

immuno-oncology

Flag link:

3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph

3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph

Yahoo/Motley Fool

Flag link:

AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more

AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more

Fierce Pharma

Gilead Sciences

Flag link:

Sanofi unveils eczema drug data, as regulators mull label expansion

Sanofi unveils eczema drug data, as regulators mull label expansion

Pharmaforum

atopic dermatitis

Flag link:

With a Bayer-Sanofi Executive Switch, Sanofi Creates Two New Global Business Units

With a Bayer-Sanofi Executive Switch, Sanofi Creates Two New Global Business Units

BioSpace

Flag link:

Sanofi to pay $25M to resolve Middle East bribery allegations

Sanofi to pay $25M to resolve Middle East bribery allegations

Fierce Pharma

Flag link:

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug

Endpoints

Flag link:

Sanofi’s rare disease drug Cablivi approved in the EU

Sanofi’s rare disease drug Cablivi approved in the EU

Pharmaforum

Flag link:

No-deal Brexit airlift? Sanofi may have to fly flu shots into the U.K. for the 2019-20 season

No-deal Brexit airlift? Sanofi may have to fly flu shots into the U.K. for the 2019-20 season

Fierce Pharma

Flag link:

AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

Endpoints

Principia Biopharma

autoimmune disease

Flag link:

Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi

Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi

Fierce Pharma

PCSK9 inhibitors

Flag link:

Pages